Mapping Oncological Therapies with MALDI MSI Technology

23 April 2019

In this video, discover how the spatial distribution of oncological therapies can be characterized using matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI MSI) technology. Using the mimetic model protocol and the MALDI SYNAPT G2-Si high definition mass spectrometer from Waters Corporation, Dr. Bindesh Shrestha demonstrates the semi-quantification of the chemotherapy drug, doxorubicin.

This interview was filmed as part of our coverage of AACR 2019 - see other video highlights here >>